JPH027577B2 - - Google Patents

Info

Publication number
JPH027577B2
JPH027577B2 JP62015574A JP1557487A JPH027577B2 JP H027577 B2 JPH027577 B2 JP H027577B2 JP 62015574 A JP62015574 A JP 62015574A JP 1557487 A JP1557487 A JP 1557487A JP H027577 B2 JPH027577 B2 JP H027577B2
Authority
JP
Japan
Prior art keywords
sulfate
polysaccharide
agent according
natural
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62015574A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6345223A (ja
Inventor
Ryuzo Ueno
Takashi Ueno
Juko Kuno
Akihiko Tabata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ueno Seiyaku Oyo Kenkyujo KK
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of JPS6345223A publication Critical patent/JPS6345223A/ja
Publication of JPH027577B2 publication Critical patent/JPH027577B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1557487A 1986-04-04 1987-01-26 ひと免疫不全ウイルス性疾患処置剤 Granted JPS6345223A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP61-78471 1986-04-04
JP61-78470 1986-04-04
JP7847086 1986-04-04
JP61-93019 1986-04-21

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP23336388A Division JPH01151521A (ja) 1986-04-04 1988-09-16 レトロウイルス性疾患処置剤

Publications (2)

Publication Number Publication Date
JPS6345223A JPS6345223A (ja) 1988-02-26
JPH027577B2 true JPH027577B2 (enrdf_load_stackoverflow) 1990-02-19

Family

ID=13662901

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1557487A Granted JPS6345223A (ja) 1986-04-04 1987-01-26 ひと免疫不全ウイルス性疾患処置剤

Country Status (3)

Country Link
JP (1) JPS6345223A (enrdf_load_stackoverflow)
ZA (1) ZA872359B (enrdf_load_stackoverflow)
ZM (1) ZM3087A1 (enrdf_load_stackoverflow)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2626892B2 (ja) * 1987-07-07 1997-07-02 味の素株式会社 新規な抗ウィルス剤
DE3734962C1 (de) * 1987-10-15 1989-01-05 Luitpold Werk Chem Pharm Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC
JPH0725802B2 (ja) * 1988-11-28 1995-03-22 味の素株式会社 カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法
EP0410002B1 (en) * 1989-02-10 1995-11-22 Taiho Pharmaceutical Co., Ltd. Anti-hiv drug
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
DK0447171T3 (da) * 1990-03-15 1994-12-12 Tanabe Seiyaku Co Polysulfat af cyclodextrinderivat og fremgangsmåde til fremstilling deraf
US5248675A (en) * 1990-03-15 1993-09-28 Tanabe Seiyaku Co., Ltd. Polysulfate of cyclodextrin derivative and process for preparing the same
JPH0491027A (ja) * 1990-08-02 1992-03-24 Taiho Yakuhin Kogyo Kk 抗ヒト免疫不全症ウィルス剤
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6022866A (en) * 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
JP2556236B2 (ja) * 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
US6147059A (en) * 1992-02-20 2000-11-14 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
DE69729958T2 (de) 1996-05-16 2005-07-28 Nissin Food Products Co., Ltd Verbindungen mit antiviraler aktivität
JP4686756B2 (ja) * 2004-03-31 2011-05-25 独立行政法人産業技術総合研究所 動物臓器から抽出した水溶性画分、その製造方法、逆転写反応阻害剤、逆転写酵素阻害剤、ウイルス増殖阻害剤及び医薬組成物
JP5976628B2 (ja) * 2013-12-18 2016-08-23 日本薬品株式会社 コンドロイチン硫酸オリゴ糖を含む免疫賦活剤及びその製造方法
JP2016164179A (ja) * 2016-04-11 2016-09-08 日本薬品株式会社 コンドロイチン硫酸オリゴ糖を含む免疫賦活剤及びその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5141083A (ja) * 1974-10-04 1976-04-06 Shigeo Suzuki Kodonoseibutsukatsuseiojusurudekisutoranhoririnsanesuteru no seizoho
EP0066379A3 (en) * 1981-05-15 1983-06-08 Riker Laboratories, Inc. Composition for combating herpes virus
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren

Also Published As

Publication number Publication date
ZM3087A1 (en) 1989-07-28
JPS6345223A (ja) 1988-02-26
ZA872359B (en) 1988-04-27

Similar Documents

Publication Publication Date Title
JPH027577B2 (enrdf_load_stackoverflow)
CA1277239C (en) Treatment of diseases caused by retroviruses
US5872109A (en) Anti-inflammatory agent
EP0270317A2 (en) Pharmaceutical compositions for the treatment of diseases caused by viruses
AU650626B2 (en) Method for producing soluble glucans
US5320849A (en) Anti-virus agent
JPH0234926B2 (enrdf_load_stackoverflow)
JP2000515543A (ja) ヘルペスウイルスにより起こる感染を予防または治療するためのキトサンと組み合わされたヘパリンまたはヘパラン硫酸の使用
CN102917711A (zh) 硫酸乙酰肝素替代疗法
CA1330305C (en) Heparin fragments and fractions with anti-hiv action
US5861382A (en) Methods for regulation of active TNF-α
CA2066155A1 (en) Antiviral agent for human immunodeficiency virus
AU699624B2 (en) Compositions for the regulation of cytokine activity
JP2003089647A (ja) 関節性疾患治療剤
HU204999B (en) Process for producing pharmaceutical compositions having antiviral activity and comprising synergetic active ingredient combination
JPH08277224A (ja) 抗炎症剤
US2832766A (en) Sulfated aminopolysaccharides
US5981509A (en) Preparation for prophylaxis or treatment of renal diseases containing sulfated polysaccharide
EA018959B1 (ru) Карбоксиэтилированные полисульфаты циклодекстрина, подходящие для применения в качестве лекарственных средств
US20050209189A1 (en) Antiviral composition
KR20010040752A (ko) 에이즈 치료제
JP4633232B2 (ja) 成長因子誘導剤
JPH0959178A (ja) 抗ウイルス剤及び抗ウイルス作用増強剤
JP4096125B2 (ja) 骨格筋成長剤
JP4528898B2 (ja) ケモカイン受容体ｃｃｒ１０の発現誘導剤